CD40-agonist: A new avenue for immunotherapy combinations in cholangiocarcinoma

In this issue of Journal of Hepatology, Diggs et  al. have investigated the antitumor activity of a novel immune-based therapeutic strategy in murine models of intrahepatic cholangiocarcinoma (iCCA).1

Source: Journal of Hepatology - February 18, 2021 Category: Gastroenterology Authors: Raffaella Casolino, Chiara Braconi Tags: Editorial Source Type: research